Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
205.85
-4.26 (-2.03%)
At close: Mar 28, 2025, 4:00 PM
205.99
+0.14 (0.07%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Danaher Market Cap
Danaher has a market cap or net worth of $147.12 billion as of March 28, 2025. Its market cap has decreased by -22.11% in one year.
Market Cap
147.12B
Enterprise Value
162.19B
1-Year Change
-22.11%
Ranking
Category
Stock Price
$205.85
Market Cap Chart
Since December 1, 1998, Danaher's market cap has increased from $6.13B to $147.12B, an increase of 2,301.85%. That is a compound annual growth rate of 12.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 147.12B | -11.26% |
Dec 31, 2024 | 165.80B | -3.01% |
Dec 29, 2023 | 170.94B | -11.53% |
Dec 30, 2022 | 193.22B | -17.82% |
Dec 31, 2021 | 235.10B | 48.98% |
Dec 31, 2020 | 157.80B | 43.14% |
Dec 31, 2019 | 110.24B | 52.53% |
Dec 31, 2018 | 72.28B | 11.94% |
Dec 29, 2017 | 64.57B | 19.92% |
Dec 30, 2016 | 53.84B | -15.41% |
Dec 31, 2015 | 63.65B | 5.68% |
Dec 31, 2014 | 60.23B | 11.90% |
Dec 31, 2013 | 53.82B | 39.00% |
Dec 31, 2012 | 38.72B | 19.93% |
Dec 30, 2011 | 32.29B | 4.66% |
Dec 31, 2010 | 30.85B | 27.69% |
Dec 31, 2009 | 24.16B | 33.51% |
Dec 31, 2008 | 18.09B | -33.56% |
Dec 31, 2007 | 27.23B | 22.14% |
Dec 29, 2006 | 22.30B | 29.74% |
Dec 30, 2005 | 17.19B | -3.00% |
Dec 31, 2004 | 17.72B | 25.76% |
Dec 31, 2003 | 14.09B | 40.70% |
Dec 31, 2002 | 10.01B | 16.16% |
Dec 31, 2001 | 8.62B | -11.14% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |